For: | Donadon M, Vauthey JN, Loyer EM, Charnsangavej C, Abdalla EK. Portal thrombosis and steatosis after preoperativechemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases. World J Gastroenterol 2006; 12(40): 6556-6558 [PMID: 17072991 DOI: 10.3748/wjg.v12.i40.6556] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i40/6556.htm |
Number | Citing Articles |
1 |
Julianna V. F. Roddy, Suzanne M. Partridge, Michelle L. Rockey, Jane M. Pruemer, Jeff J. Guo, Shaili J. Desai, Malek M. Safa. Thromboembolic Events in Patients With Colorectal Cancer Receiving the Combination of Bevacizumab-Based Chemotherapy and Erythropoietin Stimulating Agents. American Journal of Clinical Oncology 2010; 33(1): 36 doi: 10.1097/COC.0b013e31819cccaf
|
2 |
Chitra Viswanathan, Dhakshinamoorthy Ganeshan, Revathy B. Iyer. Oncologic Imaging : a Multidisciplinary Approach. 2023; : 692 doi: 10.1016/B978-0-323-69538-1.00041-0
|
3 |
Niharika Samala, Naga Chalasani. Drug-Induced Fatty Liver Disease. Current Hepatology Reports 2018; 17(3): 260 doi: 10.1007/s11901-018-0418-6
|
4 |
Abhishek R. Keraliya, Michael H. Rosenthal, Katherine M. Krajewski, Jyothi P. Jagannathan, Atul B. Shinagare, Sree Harsha Tirumani, Nikhil H. Ramaiya. Imaging of Fluid in Cancer Patients Treated With Systemic Therapy: Chemotherapy, Molecular Targeted Therapy, and Hematopoietic Stem Cell Transplantation. American Journal of Roentgenology 2015; 205(4): 709 doi: 10.2214/AJR.15.14459
|
5 |
Chitra Viswanathan, Mylene T. Truong, Tara L. Sagebiel, Yulia Bronstein, Raghunandan Vikram, Madhavi Patnana, Paul M. Silverman, Priya R. Bhosale. Abdominal and Pelvic Complications of Nonoperative Oncologic Therapy. RadioGraphics 2014; 34(4): 941 doi: 10.1148/rg.344140082
|
6 |
|
7 |
F.A. Goumas, F. Braun, D.C. Broering, M. Behrend. . Side Effects of Drugs Annual 2009; 31: 589 doi: 10.1016/S0378-6080(09)03137-7
|
8 |
Ursa Brown-Glaberman, Rachael Swart, Tomislav Dragovich, Erika Bracamonte, Sandra Kurtin, Alison Stopeck. Hepatic injury associated with bevacizumab use in metastatic breast and colon cancers: a review of two cases. Community Oncology 2008; 5(10): 539 doi: 10.1016/S1548-5315(11)70508-3
|
9 |
Yu Katayose, Michiaki Unno. Management of liver metastases from colorectal cancer. Clinical Journal of Gastroenterology 2010; 3(3): 128 doi: 10.1007/s12328-010-0155-z
|
10 |
F. Alessandrino, S.H. Tirumani, K.M. Krajewski, A.B. Shinagare, J.P. Jagannathan, N.H. Ramaiya, D.N. Di Salvo. Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors. Clinical Radiology 2017; 72(7): 521 doi: 10.1016/j.crad.2017.04.003
|
11 |
Dhakshina Moorthy Ganeshan, Usama Salem, Chitra Viswanathan, Aparna Balachandran, Naveen Garg, Paul Silverman, Priya Bhosale. Complications of oncologic therapy in the abdomen and pelvis: a review. Abdominal Imaging 2013; 38(1): 1 doi: 10.1007/s00261-012-9899-x
|
12 |
Yu Fujiwara, Takeshi Yamaguchi, Minoru Nakane. Portal Vein Thrombosis in Metastatic Colorectal Cancer During FOLFIRI-bevacizumab Chemotherapy Successfully Treated with Apixaban. Internal Medicine 2021; 60(1): 53 doi: 10.2169/internalmedicine.5456-20
|
13 |
Stacy S. Shord, Linda R. Bressler, Lauryn A. Tierney, Sandra Cuellar, Amina George. Understanding and managing the possible adverse effects associated with bevacizumab. American Journal of Health-System Pharmacy 2009; 66(11): 999 doi: 10.2146/ajhp080455
|
14 |
Chitra Viswanathan, Revathy B. Iyer. Oncologic Imaging: A Multidisciplinary Approach. 2012; : 693 doi: 10.1016/B978-1-4377-2232-1.00040-1
|
15 |
S. Zalinski, O. Scatton, S. Jacqmin, V. Tacher, C. Brézault, O. Soubrane. Portal venous gas following chemotherapy for colorectal cancer liver metastasis. European Journal of Surgical Oncology (EJSO) 2009; 35(5): 557 doi: 10.1016/j.ejso.2008.09.003
|